Saturday - February 24, 2024
House Energy & Commerce Subcommittee Issues Testimony From Mark Cuban Cost Plus Drug CEO Oshmyansky
May 17, 2023
WASHINGTON, May 17 -- The House Energy and Commerce Subcommittee on Oversight and Investigations issued the following testimony by Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Co., involving a hearing on May 11, 2023, entitled "Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains":

* * *

At the time of writing, there are approximately 200 drug products listed as in shortage on the US FDA drug shortage database. Many . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products